Form 4 for IART INTEGRA LIFESCIENCES HOLDINGS CORP
Accepted 2024-02-22 00:00:00 ET · period of report 2024-02-20 · accession 0000917520-24-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-22 | 2024-02-20 | IART | McBreen Michael J. | EVP, Pres, CSS | A - Grant | $0.00 | +3,516 | 46.0K | +8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-20 | A | A | 3,516 | $0.00 | 45,968 | D | — | — | (F1) On February 20, 2024, the Compensation Committee certified that the Company met or exceeded the average three-year annual organic revenue growth rate target for the performance period under the March 12, 2021 performance stock award. Accordingly, shares will vest on March 12, 2024, the third anniversary of the grant date. |